| Product Name | NebuSelect™ Recombinant Cynomolgus MMP-8, His-tag |
|---|---|
| Catalog Number | NBL-241603 |
| Alias/Synonyms | MMP-8 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | XP_005579523.2 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241603-100ug | 100ug | Inquire | Inquire | |
| NBL-241603-1mg | 1mg | Inquire | Inquire | |
| NBL-241603-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus MMP-8, His-tag
Catalog#:
NBL-241603
Description:
NebuSelect™ Recombinant Cynomolgus MMP-8, His-tag(Cat#NBL-241603) is expressed in HEK293 with His tag at the C-Terminus.It contains Phe21-Ser467.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 52.27 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
MMP-8
Target Information:
Alteration of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) expression has been studied for various cardiac diseases, including dilated cardiomyopathy (DCM), with the significance of surrogate markers of extracellular matrix (ECM) remodeling. MMP-8 was identified only in myocardiocytes, while MMP-9 and TIMP-2 were present in both myocardiocytes and stroma, but with different intensity. The increasing intensity of MMP-8 and TIMP-2 immunoreactions was significantly associated with low HCS.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.